Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammationValerie A. Gerriets, Jeffrey C. Rathmell, Rigel J. Kishton et al.|Journal of Clinical Investigation|2014Cited by 717
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Tewfik Miloud, Régis Josien et al.|The Lancet|2020Cited by 445
Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T CellsSteven J. Bensinger, Laurence A. Turka|The Journal of Immunology|2004Cited by 281
Thymocyte Expression of RAG-1 and RAG-2: Termination by T Cell Receptor Cross-LinkingLaurence A. Turka, Craig B. Thompson, David G. Schatz et al.|Science|1991Cited by 261
CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous systemSamia J. Khoury, Wayne W. Hancock, Enver Akalin et al.|The Journal of Immunology|1995Cited by 202